Clinical Trial Update: Safety and Efficacy of Mipomersen in Patients With Severe Hypercholesterolemia on a Maximally Tolerated Lipid-Lowering Regimen and Who Are Not on Apheresis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of mipomersen added to maximally tolerated lipid-lowering therapy in adults with severe hypercholesterolemia no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Hypercholesterolemia

Drugs mentioned

• Kynamro (mipomersen)

Snippet

Sponsor: Kastle Therapeutics, LLC | Conditions: Hypercholesterolemia, Coronary Heart Disease | Phase 3 | Status: COMPLETED | Results posted: 2013-03-21